Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29270781 | 0.86 | TP53 (0.37) | TP53MAPTALDH1A1XBP1NPSR1 | |
| SCHEMBL29270725 | 0.85 | TP53 (0.31) | TP53P2RX3MAPTLMNASMN1; SMN2 | |
| SCHEMBL29270810 | 0.83 | TP53 (0.35) | TP53MAPTALDH1A1XBP1NPSR1 | |
| SCHEMBL29270840 | 0.82 | PTGES (0.31) | TP53 | |
| SCHEMBL29270744 | 0.82 | TP53 (0.34) | TP53MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL26961711 | 0.81 | P2RX3 (0.36) | TP53P2RX3MAPT | |
| SCHEMBL29796873 | 0.81 | P2RX3 (0.36) | TP53P2RX3MAPT | |
| SCHEMBL29270828 | 0.81 | TP53 (0.34) | TP53P2RX3MAPTALDH1A1XBP1 | |
| SCHEMBL29270772 | 0.81 | TP53 (0.35) | TP53P2RX3MAPTALDH1A1XBP1 | |
| SCHEMBL29270730 | 0.80 | CNR2 (0.32) | TP53MAPTALDH1A1XBP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116964048-A | Bicyclic tetrahydroazepine derivatives for the treatment of cancer | 豪夫迈·罗氏有限公司 | 2023-10-27 | — | — | CN | disclosed |